<sup>89</sup>Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NF<i>κ</i>B and JNK Signaling

<div>Immunohistochemistry of EL4 tumor tissue of mice with and without PMA treatment. CD8<i>α</i> staining showing tumor-infiltrating effector lymphocytes (a) and PD-1 staining of tumor cells and lymphocytes (b) in tumors of control and PMA-treated mice. Magnification, ×12.5 (left) and ×200 (right).</div>

Molecular Imaging

fig7

Figure 7

Figure 7: <sup>89</sup>Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NF<i>κ</i>B and JNK Signaling 

Molecular Imaging

89Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling

Figure 7

⁸⁹Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling